Brain surgery meets brain science: probing how a memory-related chemical system influences cognition

NCT ID NCT07721272

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study investigates how a drug called Cobenfy KarXT, which affects the brain's cholinergic (acetylcholine) system, alters brain activity during memory and thinking tasks. About 30 people with essential tremor or epilepsy who are already scheduled for deep brain stimulation (DBS) surgery will take either the drug or a placebo before their procedure. During awake surgery, researchers will use a clinical brain probe to record electrical signals while participants perform cognitive tasks, aiming to understand how cholinergic circuits support learning, memory, and cognitive control.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cobenfy KarXT (xanomeline-trospium) pill or placebo, given once before surgery
What this could lead to
If it works, this could reveal how the brain's cholinergic system supports memory and decision-making, pointing toward new treatments for cognitive disorders.
What could go wrong
This is a very early, small study (30 people) focused on measuring brain signals, not treating disease. Results may not apply to broader populations or lead directly to therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE CONTROL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.